asia pacific artificial intelligence (ai) in drug discovery market

Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity

  • Published Date: 2020-10-15
  • Report ID: 2296
  • Pages: 121
  • Format: prudent report format

Asia Pacific artificial intelligence (AI) in drug discovery will grow by 33.2% over 2020-2026 with a total addressable market cap of $2.78 billion owing to fast adoption of AI technology in pharmaceutical industry and drug development.
Highlighted with 34 tables and 53 figures, this 121-page report Asia Pacific Artificial Intelligence (AI) in Drug Discovery Market 2020-2026 by Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country: Trend Forecast and Growth Opportunity is based on a comprehensive research of the entire Asia Pacific AI in drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report provides historical market data for 2015-2019, revenue estimates for 2020, and forecasts from 2021 till 2026. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
Market Structure
Growth Drivers
Restraints and Challenges
Emerging Product Trends & Market Opportunities
Porters Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify Asia Pacific AI in drug discovery market in every aspect of the classification from perspectives of Offering, Technology, Drug Type, Therapeutic Area, Application, End User, and Country.
Based on offering, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Software
Service
Based on technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Deep Learning
Supervised Learning
Reinforcement Learning
Unsupervised Learning
Other Technologies
Based on drug type, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Large-molecule Drugs
Small-molecular Drugs
Based on therapeutic area, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Oncology
Neurodegenerative Diseases
Cardiovascular Disease
Metabolic Diseases
Other Therapeutic Areas
Based on application, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Information & Data Analysis
Drug Design
Drug Evaluation
Clinical Trials
Other Applications
Based on end user, the Asia Pacific market is segmented into the following sub-markets with annual revenue for 2015-2026 (historical and forecast) included in each section.
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
Geographically, the following national/local markets are fully investigated:
Japan
China
South Korea
Australia
India
Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
For each of the aforementioned countries, detailed analysis and data for annual revenue are available for 2015-2026. The breakdown of key national markets by Technology, Therapeutic Area, and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Specifically, potential risks associated with investing in Asia Pacific AI in drug discovery market are assayed quantitatively and qualitatively through GMDs Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions.
Key Players (this may not be a complete list and extra companies can be added upon request):
Atomwise, Inc.
BenevolentAI
Berg LLC
Bioage
BIOAGE
Cloud Pharmaceuticals, Inc.
Cyclica
Deep Genomics
Envisagenics
Exscientia
Google
IBM Corporation
Insilico Medicine
Microsoft Corporation
Numedii, Inc.
Numerate
NVIDIA Corporation
Owkin, Inc.
Twoxar, Incorporated
Verge Genomics
Xtalpi, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)


1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.2 Major Growth Drivers 22
2.3 Market Restraints and Challenges 25
2.4 Emerging Opportunities and Market Trends 28
2.5 Porters Fiver Forces Analysis 32
3 Segmentation of Asia Pacific Market by Offering 36
3.1 Market Overview by Offering 36
3.2 Software 38
3.3 Service 39
4 Segmentation of Asia Pacific Market by Technology 40
4.1 Market Overview by Technology 40
4.2 Deep Learning 42
4.3 Supervised Learning 43
4.4 Reinforcement Learning 44
4.5 Unsupervised Learning 45
4.6 Other Technologies 46
5 Segmentation of Asia Pacific Market by Drug Type 47
5.1 Market Overview by Drug Type 47
5.2 Large-molecule Drugs 49
5.3 Small-molecular Drugs 50
6 Segmentation of Asia Pacific Market by Therapeutic Area 51
6.1 Market Overview by Therapeutic Area 51
6.2 Oncology 54
6.3 Neurodegenerative Diseases 55
6.4 Cardiovascular Disease 56
6.5 Metabolic Diseases 57
6.6 Other Therapeutic Areas 58
7 Segmentation of Asia Pacific Market by Application 59
7.1 Market Overview by Application 59
7.2 Information & Data Analysis 61
7.3 Drug Design 62
7.4 Drug Evaluation 63
7.5 Clinical Trials 64
7.6 Other Applications 65
8 Segmentation of Asia Pacific Market by End User 66
8.1 Market Overview by End User 66
8.2 Pharmaceutical & Biotechnology Companies 68
8.3 Academic & Research Institutes 69
8.4 Contract Research Organizations 70
9 Asia-Pacific Market 2019-2026 by Country 71
9.1 Overview of Asia-Pacific Market 71
9.2 China 74
9.3 Japan 76
9.4 India 79
9.5 Australia 81
9.6 South Korea 83
9.7 Rest of APAC Region 85
10 Competitive Landscape 87
10.1 Overview of Key Vendors 87
10.2 New Product Launch, Partnership, Investment, and M&A 92
10.3 Company Profiles 93
Atomwise, Inc. 93
BenevolentAI 95
Berg LLC 96
Bioage 97
BIOAGE 98
Cloud Pharmaceuticals, Inc. 99
Cyclica 100
Deep Genomics 101
Envisagenics 102
Exscientia 103
Google 104
IBM Corporation 105
Insilico Medicine 106
Microsoft Corporation 107
Numedii, Inc. 108
Numerate 109
NVIDIA Corporation 110
Owkin, Inc. 111
Twoxar, Incorporated 112
Verge Genomics 113
Xtalpi, Inc. 114
11 Investing in Asia Pacific Market: Risk Assessment and Management 115
11.1 Risk Evaluation of Asia Pacific Market 115
11.2 Critical Success Factors (CSFs) 118
Related Reports and Products 121
CHOOSE LICENCE TYPE
prudent payment methods
Contact Us

Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071

Drop us an email at
sales@prudentmarkets.com

Why Choose Us
24 * 7 Access to Analyst :

Get your pre and post sales queries resolved by our Subject matter experts.

Customization :

We will assist you to customize the report to fit your research needs.

Assured Quality :

Our prime focus is to provide qualitative and accurate data.

Free sample report :

Feel free to order a sample report before purchase.

Security :

Your personal and confidential information is safe and secured.